GLIS2 and acute promyelocytic leukemia: CBFA2T3::GLIS2 is not specific to AMKL and occurs in diverse morphologic subtypes of de novo AML (except for acute promyelocytic leukemia (APL) and leukemia with erythroid differentiation), overall found in approximately 8.4% of cytogenetically normal AML cases (Masetti et al., 2013a; Smith et al., 2020).